ARTV: ARTIVA BIOTHERAPEUTICS, INC. insider trading, 5% holders and institutional ownership

From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.

Insider trading

0 open-market buys totaling - and 5 sales totaling $726K in the last 180 days.

Insider sales

Trade dateInsiderRoleValue10b5-1 plan
2026-10-06Aslan FredCEO$169Kyes
2026-10-05Horan ChristopherOfficer$71K
2026-10-05Bush JenniferOfficer$57K
2026-10-05Banerjee SubhashisOfficer$8K
2026-10-05Aslan FredCEO$422K

Activist and 5% holders

FiledWhatHolderStakeChangeFiling
2026-08-14Fell below 5%Venrock Healthcare Capital Partners III, L.P.4.20%SEC
2026-08-10Fell below 5%5AM Ventures VI, L.P.4.80%SEC

Institutional ownership (Q2 2026)

72 institutions reported holding $394.32M of ARTIVA BIOTHERAPEUTICS, INC. on Form 13F (40 the quarter before). 39 opened a new position and 7 sold out. Shares held by institutions: +142%.

Largest holdersSharesValue
RA CAPITAL MANAGEMENT, L.P.17,955,642$174.17M
VIKING GLOBAL INVESTORS LP2,604,166$25.26M
Blackstone Inc.2,403,437$23.31M
5AM Venture Management, LLC2,353,304$22.83M
Venrock Adviser, LLC2,043,596$19.82M
FRANKLIN RESOURCES INC1,997,223$19.37M
Caligan Partners LP1,736,111$16.84M
VANGUARD CAPITAL MANAGEMENT LLC981,815$9.52M
SAMSARA BIOCAPITAL, LLC954,861$9.26M
Blue Owl Capital Holdings LP874,542$8.48M

Get new insider and activist filings the morning after: daily alerts. Not investment advice.